http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#head http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#assertion http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#assertion http://bio2rdf.org/drugbank:DB00176 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00344 http://bio2rdf.org/drugbank:DB00344 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00344 http://bio2rdf.org/drugbank_resource:DB00176_DB00344 http://purl.org/dc/terms/identifier drugbank_resource:DB00176_DB00344 http://bio2rdf.org/drugbank_resource:DB00176_DB00344 http://purl.org/dc/terms/title DDI between Fluvoxamine and Protriptyline - The SSRI, fluvoxamine, may increase the serum concentration of the tricyclic antidepressant, protriptyline, by decreasing its metabolism. Additive modulation of serotonin activity also increases the risk of serotonin syndrome. Monitor for development of serotonin syndrome during concomitant therapy. Monitor for changes in the therapeutic and adverse effects of protriptyline if fluvoxamine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00176_DB00344 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00176_DB00344 http://www.w3.org/2000/01/rdf-schema#label DDI between Fluvoxamine and Protriptyline - The SSRI, fluvoxamine, may increase the serum concentration of the tricyclic antidepressant, protriptyline, by decreasing its metabolism. Additive modulation of serotonin activity also increases the risk of serotonin syndrome. Monitor for development of serotonin syndrome during concomitant therapy. Monitor for changes in the therapeutic and adverse effects of protriptyline if fluvoxamine is initiated, discontinued or dose changed. [drugbank_resource:DB00176_DB00344] http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#signature.MC0CFQCGH6bLOhF2 http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#signature.MC0CFQCGH6bLOhF2 http://purl.org/nanopub/x/hasSignature MC0CFQCGH6bLOhF2YKNgLG1i1Kb9wiksggIUWNRLzRiM+LWaOaa0Oa82hbMS9Z8= http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#signature.MC0CFQCGH6bLOhF2 http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://purl.org/dc/terms/created 2018-03-30T11:12:36.747+02:00 http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8#signature.MC0CFQCGH6bLOhF2 http://bio2rdf.org/drugbank_resource:DB00176_DB00344_nanopub.RAQT-OU7En6yymUV21XRpIVIR6FdgCx5UbGK6n2xi4CQ8 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234